Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Morphine In The Dosage Forms Smt/ Tab. 2026-03-02
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Preiconazole In The Dosage Form Pse. 2026-03-02
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Drugs With The Active Ingredient Certolizumab Pegol (atccode 2026-03-02
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Certolizumab Pegol. Certolizumab Pegol 2026-03-02
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Combination Timolol + Tafluprost In The Daring Form Edp 2026-03-02
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Liraglutide In The Dosage Form Ilo - Medicinal Product 2026-03-02
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Budesonide In The Power Strength 3mg And In The Dosage Forms Hvw/kpg - Medicinal Products (cpv Code: 33600000) 2026-03-02
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-03-02
Germany Completion Of Non -existing Discount Agreements According To § 130 A Para. 8 Sgb V From 01.10.2025 2026-03-02
Germany Openhouse Medicinal Practice Departments In Accordance With Section 130a Par. 8c Sgb V Eribulin, Atc L01xx41 Contract Regions Of Lower Saxony, Bremen And Sachsenanhalt 2026-03-02
Whats app